Table 1.
Metabolic Syndrome Features, Intra-Abdominal Fat Area, and Fasting Insulin Level by Sex
| Feature† | Men (n=260) | Women (n=239) |
|---|---|---|
| Hyperglycemia | 139 (53.5%) | 118 (49.4%) |
| Hypertension | 140 (53.9%) | 87 (36.4%) |
| Dyslipidemia | 104 (40.0%) | 55 (23.0%) |
| Waist Circumference | 102 (39.2%) | 70 (29.3%) |
| IAF | 65 (25.0%) | 60 (25.1%) |
| Fasting Insulin | 55 (21.2%) | 76 (31.8%) |
†
The following cut-points were used: hyperglycemia (fasting plasma glucose ≥ 5.6 mmol/l), hypertension (systolic blood pressure ≥ 130 mm Hg or diastolic blood pressure ≥ 85 mm Hg), dyslipidemia (triglycerides ≥ 1.7 mmol/l or HDL < 1.03 mmol/l in men, < 1.29 mmol/l in women, or treatment with a lipid-lowering medication), waist circumference (≥ 80 cm women or ≥ 90 cm men), IAF (intra-abdominal fat area upper quartile > 129.8 cm2 men, > 91.3 cm2 women), fasting insulin (upper quartile > 111 pmol/l).